What is Snap Diagnostics?
Founded in 1994 and headquartered in Wheeling, Illinois, Snap Diagnostics operates as a specialized medical device and service provider. The company is primarily focused on the development, manufacturing, and commercialization of advanced diagnostic tools designed to identify, analyze, and manage obstructive sleep apnea. By integrating proprietary technology into clinical workflows, Snap Diagnostics addresses a critical gap in respiratory health management, providing healthcare providers with actionable data to improve patient outcomes. Its market position is defined by a commitment to precision diagnostics and a long-standing history of innovation in the sleep medicine domain.
How much funding has Snap Diagnostics raised?
Snap Diagnostics has raised a total of $2.5M across 2 funding rounds:
Debt
$1M
Debt
$1.5M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.5M led by PPP
Key Investors in Snap Diagnostics
PPP
Public-Private Partnership
What's next for Snap Diagnostics?
With the recent capital injection, Snap Diagnostics is well-positioned to scale its diagnostic service offerings and enhance its manufacturing capabilities. The company is expected to prioritize the expansion of its market footprint, potentially through increased investment in research and development to address evolving clinical requirements in sleep medicine. As the firm transitions into this next phase of growth, the focus will likely remain on optimizing diagnostic accuracy and streamlining the delivery of its medical services to a broader patient demographic, thereby reinforcing its status as a key player in the obstructive sleep apnea diagnostic market.
See full Snap Diagnostics company page
